FdaApplication
NDA 212516
Identifiers
- fda_app_no: NDA212516
Properties
| Property | Value |
|---|---|
| applicant_name | SUN PHARMACEUTICAL INDUSTRIES LTD |
| application_type | NDA |
| approval_date | 2019-07-19 |
Products (4)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DRIZALMA SPRINKLE | DULOXETINE HYDROCHLORIDE | EQ 40MG BASE | CAPSULE, DELAYED REL PELLETS;ORAL |
| DRIZALMA SPRINKLE | DULOXETINE HYDROCHLORIDE | EQ 30MG BASE | CAPSULE, DELAYED REL PELLETS;ORAL |
| DRIZALMA SPRINKLE | DULOXETINE HYDROCHLORIDE | EQ 20MG BASE | CAPSULE, DELAYED REL PELLETS;ORAL |
| DRIZALMA SPRINKLE | DULOXETINE HYDROCHLORIDE | EQ 60MG BASE | CAPSULE, DELAYED REL PELLETS;ORAL |
4 products